J.P.Morgan Asset & Wealth Management, one of the largest global investment managers, has announced it will stop using third‑party proxy advisory firms for U.S. proxy voting and will instead rely on a newly launched internal, AI‑powered platform, Proxy IQ, to manage all aspects of the voting process for more than 3,000 company annual meetings.

Transitioning from discovery to clinical development marks a defining moment for emerging biotech companies. It’s also a time to consider evolving your IP strategy from protecting ideas to protecting assets.